The kidney expression of matrix metalloproteinase-9 in the diabetic nephropathy of Kkay mice

Journal of Diabetes and its Complications

Volumn 22, Issue 6, 2008, Pages 408-412

  Qing Hua, Guo ^a   Ju Ming, Lu ^a   Chang Yu, Pan ^a   Zhao Hui, Lu ^a   Xiao Man, Zou ^a   Yi Ming, Mu ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Diabetic nephropathy; Kkay mice; Matrix metalloproteinase 9

Indexed keywords

GELATINASE B; GLUCOSE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIET; GLOMERULOSCLEROSIS; GLOMERULUS; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY PARENCHYMA; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PERIODIC ACID SILVER METHENAMINE STAINING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY GLOMERULUS; MATRIX METALLOPROTEINASE 9; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 54049131275     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2007.10.002     Document Type: Article

References (15)

1. Chen L.M., Li X.W., Huang L.W., Li Y., Duan L., and Zhang X.J. The early pathological changes of KKAy mice with type 2 diabetes. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24 (2002) 71-75
2. Ebihara I., Nakamura T., Shimada N., and Koide H. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. American Journal of Kidney Diseases 32 (1998) 544-550
3. Fornoni A., Wang Y., Lenz O., Striker L.J., and Striker G.E. Association of a decreased number of d(CA) repeats in the matrix metalloproteinase-9 promoter with glomerulosclerosis susceptibility in mice. Journal of the American Society of Nephrology 13 (2002) 2068-2076
4. Iwatasuka H., Shimo A., and Suzuoki Z. General survey of diabetic features of yellow KK mice. Endocrinologia Japonica 17 (1970) 23-35
5. Johnson L.L., Dyer R., and Hupe D.J. Matrix metalloproteinases. Current Opinion in Chemical Biology 2 (1998) 466-471
6. Mott J.D., Khalifah R.G., Nagase H., Shield C.F., Hudson J.K., and Hudson B.G. Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. Kidney International 52 (1997) 1302-1312
7. Murphy G., and Docherty A.J.P. The matrix metalloproteinases and their inhibitors. American Journal of Respiratory Cell and Molecular Biology 7 (1992) 120-125
8. Nakamura T., Fukui M., and Ebihara I. Abnormal gene expression of matrix metalloproteinase and its inhibitor in glomeruli from diabetic rats. Renal Physiology and Biochemistry 17 (1994) 316-325
9. Nakamura T., Ushiyama C., and Suzuki S. Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrology, Dialysis, Transplantation 15 (2000) 1379-1383
10. Raij I., Azar S., and Keane W. Mesangial immune injury, hypertension and progression glomerular damage in Dahl rats. Kidney International 26 (1984) 137-146
11. Schaefer L., Han X., and August C. Differential regulation of glomerular gelaginase B (MMP-9) and tissue inhibitor of metalloproteinase-1(TIMP-1) in obese Zucker rats. Diabetologia 4 (1997) 1035-1043
12. Sun S.Z., Wang Y., Li Q., Tian Y.J., Liu M.H., and Yu Y.H. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats. Chinese Medical Journal 119 (2006) 814-821
13. Tashiro K., Koyanagi I., Ohara I., Ito T., Saitoh A., Horikoshi S., et al. Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy. Journal of Clinical Laboratory Analysis 18 (2004) 206-210
14. Tsilibary E.C. Microvascular basement membranes in diabetes mellitus. Journal of Pathology 4 (2003) 537-546
15. Zaoui P., Cantin J.F., Alimardani-Bessette M., Monier F., Halimi S., Morel F., et al. Role of metalloproteases and inhibitors in the occurrence and progression of diabetic renal lesions. Diabetes & Metabolism 26 Suppl. (2000) 25-29